NVST
NYSE
US
Envista Holdings Corporation Common Stock
$27,73
▲ +$0,79
(+2,93%)
Vol. 54K
Cap. mercato
$4.4B
P/E
93,9
ROE
1,5%
Margine
1,7%
Beta
0,98
52W
$15–$30
Consenso Wall Street
20 analisti · Apr 20267
Acquisto forte
5
Compra
8
Mantieni
0
Vendi
0
Vendita forte
60,0%
Rating Compra
Grafico dei Prezzi
Titoli simili
MASI
Masimo Corp
$7.0B
BAX
Baxter International Inc
$9.3B
GKOS
Glaukos Corp
$7.1B
TFX
Teleflex Inc
$5.7B
IRTC
iRhythm Holdings, Inc
$5.7B
TMDX
Transmedics Group Inc
P/E 45,3
$4.2B
ITGR
Integer Holdings Corp
P/E 29,6
$3.0B
LMAT
LeMaitre Vascular Inc
P/E 34,5
$1.8B
AORT
Artivion Inc
P/E 183,1
$1.8B
ABT
Abbott Laboratories
P/E 26,3
$165.2B
Utili
Tasso di battuta: 100,0%| Trimestre | EPS Stimato | EPS Effettivo | Sorpresa |
|---|---|---|---|
| Dic 2025 | $0,33 | $0,38 | +$0,05 |
| Set 2025 | $0,28 | $0,32 | +$0,04 |
| Giu 2025 | $0,24 | $0,26 | +$0,02 |
| Mar 2025 | $0,21 | $0,24 | +$0,03 |
Ricavi e utili trimestrali
| Trimestre | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Ricavi | — | $652.9M | $616.9M | $682.1M | $669.9M | $750.6M |
| Utile netto | — | $1.2M | $18.0M | $26.4M | -$30.3M | $32.9M |
Trend fondamentali
| Metrica | 2026-04-12 | 2026-04-17 |
|---|---|---|
| ROE (TTM) | 1.5% | 1.5% |
| P/E (TTM) | 92.01 | 93.93 |
| Net Margin | 1.7% | 1.7% |
| Gross Margin | 55.0% | 55.0% |
| D/E Ratio | — | — |
| Current Ratio | 2.38 | 2.38 |
Rapporti chiave
ROA (TTM)
0,8%
P/S (TTM)
1,62
P/B
1,1
EPS (TTM)
$0,28
CF/Share
$1,87
Crescita ricavi 3A
+1,9%
52W High
$30,42
52W Low
$14,72
$14,72
Intervallo 52 settimane
$30,42
Salute finanziaria
Flusso di cassa libero
$91.7M
Debito netto
$386.0M
Liquidità
$1.2B
Debito totale
$1.6B
Aggiornato al Dic 31, 2025
Як NVST виглядає на тлі конкурентів у Health Care?
Група порівняння: Peers · Health Care (Peers) · 10 компаній
Оцінка NVST vs аналоги Health Care
P/E
92,0
▲
167%
sopra
peer
(34,5)
vs Peer
vs Settore
Più costoso
P/S
1,6
▼
60%
sotto
peer
(4,0)
vs Peer
vs Settore
Sottovalutato
P/B
1,2
▼
78%
sotto
peer
(5,2)
vs Peer
vs Settore
Sottovalutato
Дивідендна дохідність
—
▼
0%
sotto
peer
(1,1%)
vs Peer
vs Settore
In linea
Прибутковість NVST vs аналоги Health Care
ROE
1,5%
▲
125%
sopra
peer
(-6,1%)
vs Peer
vs Settore
Sotto media
Net margin
1,7%
▲
162%
sopra
peer
(-2,8%)
vs Peer
vs Settore
Sotto media
Валова маржа
55,0%
▼
1%
sotto
peer
(55,9%)
vs Peer
vs Settore
In linea
ROA
0,8%
▲
145%
sopra
peer
(-1,9%)
vs Peer
vs Settore
Sotto media
Фінансове здоровʼя NVST vs аналоги Health Care
D/E ratio
—
▼
0%
sotto
peer
(106,5)
vs Peer
vs Settore
In linea
Поточна ліквідність
2,4
▼
23%
sotto
peer
(3,1)
vs Peer
vs Settore
Liquidità bassa
Beta
1,0
▲
24%
sopra
peer
(0,8)
vs Peer
vs Settore
Più volatile
Радар фундаменталів NVST
NVST
Mediana peer
Industria
NVST прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
NVST vs аналоги: ключові метрики
Attività insider
BearishAcquisti
8
Vendite
1
$290250
HAMMES ERIC D.
Chief Financial Officer · Feb 25
award
16055 shs
KEEL PAUL A
Chief Executive Officer · Feb 25
award
48670 shs
NANCE MARK E
General Counsel · Feb 25
award
12675 shs
REIS MISCHA
Officer · Feb 25
award
5915 shs
KAABI FAEZ C
Officer · Feb 25
award
13520 shs
BEFIDI ROBERT JR.
Officer · Feb 25
award
7605 shs
ACURIO VERONICA
Officer · Feb 25
award
7605 shs
NILSSON STEFAN
Officer · Feb 25
award
7605 shs
REIS MISCHA
Officer · Feb 10
sale
9675 shs
REIS MISCHA
Officer · Feb 10
conversion of exercise of derivative security
9675 shs
Ultimo 90 giorni
Principali azionisti
Top 5: 39,3%Blackrock Inc.
10,76%
$462.9M
Vanguard Group Inc
9,88%
$424.8M
Ariel Investments, LLC
7,34%
$315.9M
Dimensional Fund Advisors LP
5,91%
$254.1M
Morgan Stanley
5,41%
$232.5M
Aggiornato al Dic 31, 2025
Ultime notizie
Nessuna notizia correlata ancora